ST14
Reaktivität: Human
WB, ELISA, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA (1:1000) Western Blot (1:100-500) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Oberst, Williams, Dickson, Johnson, Lin: "The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor." in: The Journal of biological chemistry, Vol. 278, Issue 29, pp. 26773-9, (2003) (PubMed).
Santin, Cane, Bellone, Bignotti, Palmieri, De Las Casas, Anfossi, Roman, OBrien, Pecorelli: "The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma." in: Cancer, Vol. 98, Issue 9, pp. 1898-904, (2003) (PubMed).
Ihara, Miyoshi, Ko, Murata, Nakahara, Honke, Dickson, Lin, Taniguchi: "Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching." in: The Journal of biological chemistry, Vol. 277, Issue 19, pp. 16960-7, (2002) (PubMed).
Target
ST14
(Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))